Myriad Genetics
MYGN
#7304
Rank
โ‚น53.84 B
Marketcap
โ‚น570.14
Share price
-0.17%
Change (1 day)
48.39%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น32.44 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are โ‚น32.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น30.39 B8.52%
2024-12-31โ‚น28.00 B-7.39%
2023-12-31โ‚น30.24 B16.81%
2022-12-31โ‚น25.89 B-1.42%
2021-12-31โ‚น26.26 B
2020-06-30โ‚น36.84 B12.8%
2019-06-30โ‚น32.66 B128.12%
2018-06-30โ‚น14.31 B-49.74%
2017-06-30โ‚น28.49 B218.79%
2016-06-30โ‚น8.93 B35.01%
2015-06-30โ‚น6.61 B5.33%
2014-06-30โ‚น6.28 B40.35%
2013-06-30โ‚น4.47 B46.74%
2012-06-30โ‚น3.05 B55.41%
2011-06-30โ‚น1.96 B16.67%
2010-06-30โ‚น1.68 B9.34%
2009-06-30โ‚น1.53 B-51.33%
2008-06-30โ‚น3.16 B121.82%
2007-06-30โ‚น1.42 B14.72%
2006-06-30โ‚น1.24 B22.7%
2005-06-30โ‚น1.01 B46.7%
2004-06-30โ‚น0.69 B-22.97%
2003-06-30โ‚น0.89 B-35.7%
2002-06-30โ‚น1.39 B-9%
2001-06-30โ‚น1.53 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Abbott Laboratories
ABT
โ‚น5.569 T 17,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚น333.74 B 928.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น229.49 B 607.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚น2.10 B-93.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น283.49 B 773.83%๐Ÿ‡บ๐Ÿ‡ธ USA